Interestingly, in this patient subgroup, the IFN-γ/IL-17F ratio discriminated CIS from MS and RRMS more accurately than IL-17F alone, supporting the notion that in some cases, the ratio between cytokines rather than individual cytokines might better reflect disease progression. Here, IL17F is linked to myeloid sarcoma.